Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Several employees have sued health insurance companies for excluding coverage of GLP-1 medications prescribed solely to treat obesity, arguing that such obesity exclusion constitutes disability discrimination under the ACA
Saxenda is FDA-approved for the treatment of obesity, while Victoza is approved for the treatment of type 2 diabetes in patients ages ten and older
Real relationship, real results
Diabetes-related complications: Health issues like kidney disease, nerve damage, or vision loss that can arise from unmanaged diabetes
Jun 2013;7(2):207-222
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
US$ 28.16
US$ 22.43
US$ 21.90
US$ 28.56
US$ 22.08
US$ 26.00
